News Non-Vitamin K Antagonist Oral Anticoagulants vs Warfarin in NVAF Patients Publish Date August 20, 2021 Findings may help with decision-making in this high-risk patient population.
News Pradaxa Approved to Treat, Prevent VTE in Pediatric Patients Publish Date June 22, 2021 Pradaxa oral pellets are supplied in child-resistant packets in 20mg, 30mg, 40mg, 50mg, 110mg, and 150mg dosage strengths.